Paper24906989
In vitro and in vivo activity of major constituents from Pluchea carolinensis against Leishmania amazonensis.
Montrieux E and 5 others. Parasitol Res, 2014. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. In vitro and in vivo activity of major constituents from Pluchea carolinensis against Leishmania amazonensis. Papers, record 24906989. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24906989
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro and in vivo activity of major constituents from Pluchea carolinensis against Leishmania amazonensis.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiprotozoal Agents | Major topic |
| Asteraceae | Major topic |
| Leishmania mexicana | Major topic |
| Leishmaniasis | Major topic |
| Animals | |
| Caffeic Acids | |
| Cells, Cultured | |
| Cinnamates | |
| Coumaric Acids | |
| Depsides | |
| Female | |
| Macrophages | |
| Mice | |
| Mice, Inbred BALB C | |
| Quercetin | |
| Rosmarinic Acid |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11179920 | Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches. | Int J Infect Dis | 2000 | https://conductscience.org/library/papers/11179920 | PubMed |
| 2 | 16961529 | Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis. | Int J Dermatol | 2006 | https://conductscience.org/library/papers/16961529 | PubMed |
| 3 | 21131319 | In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species. | J Antimicrob Chemother | 2011 | https://conductscience.org/library/papers/21131319 | PubMed |
| 4 | 21346801 | Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis. | PLoS One | 2011 | https://conductscience.org/library/papers/21346801 | PubMed |
| 5 | 8423364 | An improved MTT assay. | J Immunol Methods | 1993 | https://conductscience.org/library/papers/8423364 | PubMed |
| 6 | 9579209 | Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration. | Ann Trop Med Parasitol | 1997 | https://conductscience.org/library/papers/9579209 | PubMed |
| 7 | 16008131 | A review of natural products with antileishmanial activity. | Phytomedicine | 2005 | https://conductscience.org/library/papers/16008131 | PubMed |
| 8 | 8913444 | In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8913444 | PubMed |
| 9 | 20886232 | Anti-leishmanial effects of purified compounds from aerial parts of Baccharis uncinella C. DC. (Asteraceae). | Parasitol Res | 2011 | https://conductscience.org/library/papers/20886232 | PubMed |
| 10 | 20064628 | Evaluation of antileishmanial activity of eupomatenoid-5, a compound isolated from leaves of Piper regnellii var. pallescens. | Parasitol Int | 2010 | https://conductscience.org/library/papers/20064628 | PubMed |
| 11 | 23392902 | Voriconazole suppresses the growth of Leishmania species in vitro. | Parasitol Res | 2013 | https://conductscience.org/library/papers/23392902 | PubMed |
| 12 | 8092835 | Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8092835 | PubMed |
| 13 | 22566939 | Subversion and Utilization of Host Innate Defense by Leishmania amazonensis. | Front Immunol | 2012 | https://conductscience.org/library/papers/22566939 | PubMed |
| 14 | 22014743 | Antileishmanial assessment of leaf extracts from Pluchea carolinensis, Pluchea odorata and Pluchea rosea. | Asian Pac J Trop Med | 2011 | https://conductscience.org/library/papers/22014743 | PubMed |
| 15 | 21933304 | Clinical pleiomorphism in human leishmaniases, with special mention of asymptomatic infection. | Clin Microbiol Infect | 2011 | https://conductscience.org/library/papers/21933304 | PubMed |
| 16 | 9087483 | Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9087483 | PubMed |
| 17 | 8170156 | Leishmanicidal and trypanocidal activities of Bolivian medicinal plants. | J Ethnopharmacol | 1994 | https://conductscience.org/library/papers/8170156 | PubMed |
| 18 | 8540741 | Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/8540741 | PubMed |
| 19 | 20954722 | Caffeic acid esters and lignans from Piper sanguineispicum. | J Nat Prod | 2010 | https://conductscience.org/library/papers/20954722 | PubMed |
| 20 | 22888328 | Conventional therapy and promising plant-derived compounds against trypanosomatid parasites. | Front Microbiol | 2012 | https://conductscience.org/library/papers/22888328 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40333153 | Caffeic Acid Phenethyl Ester (CAPE) Inhibits Arginase Activity and Growth of Leishmania amazonensis Promastigotes and Intracellular Amastigotes. | Pathogens | 2025 | https://conductscience.org/library/papers/40333153 | PubMed |
| 39411680 | Investigation the effect of the aqueous extract of Chara vulgaris (L.) on visceral leishmaniasis. | Trop Parasitol | 2024 | https://conductscience.org/library/papers/39411680 | PubMed |
| 39145371 | In vitro anthelmintic efficacy of Ferulic and Sinapic acid against zoonotic cestode Hymenolepis diminuta (Rudolphi, 1819). | J Parasit Dis | 2024 | https://conductscience.org/library/papers/39145371 | PubMed |
| 38682892 | Effects of dietary water-soluble extract of rosemary supplementation on growth performance and intestinal health of broilers infected with Eimeria tenella. | J Anim Sci | 2024 | https://conductscience.org/library/papers/38682892 | PubMed |
| 38632113 | Piperine, quercetin, and curcumin identified as promising natural products for topical treatment of cutaneous leishmaniasis. | Parasitol Res | 2024 | https://conductscience.org/library/papers/38632113 | PubMed |
| 38456097 | Quercetin as a Promising Antiprotozoan Phytochemical: Current Knowledge and Future Research Avenues. | Biomed Res Int | 2024 | https://conductscience.org/library/papers/38456097 | PubMed |
| 38004459 | Design, Synthesis, and Repurposing of Rosmarinic Acid-β-Amino-α-Ketoamide Hybrids as Antileishmanial Agents. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/38004459 | PubMed |
| 36835023 | Towards Arginase Inhibition: Hybrid SAR Protocol for Property Mapping of Chlorinated N-arylcinnamamides. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36835023 | PubMed |
| 36559012 | Human Lung Cancer (A549) Cell Line Cytotoxicity and Anti-Leishmania major Activity of Carissa macrocarpa Leaves: A Study Supported by UPLC-ESI-MS/MS Metabolites Profiling and Molecular Docking. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/36559012 | PubMed |
| 36399160 | In vitro and in vivo therapeutic antileishmanial potential of ellagic acid against Leishmania donovani in murine model. | Med Microbiol Immunol | 2023 | https://conductscience.org/library/papers/36399160 | PubMed |
| 36145452 | In Vitro and In Silico Analyses of New Cinnamid and Rosmarinic Acid-Derived Compounds Biosynthesized in Escherichia coli as Leishmania amazonensis Arginase Inhibitors. | Pathogens | 2022 | https://conductscience.org/library/papers/36145452 | PubMed |
| 35551517 | Can floral nectars reduce transmission of Leishmania? | PLoS Negl Trop Dis | 2022 | https://conductscience.org/library/papers/35551517 | PubMed |
| 34946555 | In Vitro Antileishmanial and Antischistosomal Activities of Anemonin Isolated from the Fresh Leaves of Ranunculus multifidus Forsk. | Molecules | 2021 | https://conductscience.org/library/papers/34946555 | PubMed |
| 34789984 | GC-MS screening and antiparasitic action of Putranjiva roxburghii leaves against sensitive and resistant strains of Leishmania donovani. | J Parasit Dis | 2021 | https://conductscience.org/library/papers/34789984 | PubMed |
| 33525448 | Natural Products That Target the Arginase in Leishmania Parasites Hold Therapeutic Promise. | Microorganisms | 2021 | https://conductscience.org/library/papers/33525448 | PubMed |
| 33330368 | Use of Natural Products in Leishmaniasis Chemotherapy: An Overview. | Front Chem | 2020 | https://conductscience.org/library/papers/33330368 | PubMed |
| 33198198 | Cinnamides Target Leishmania amazonensis Arginase Selectively. | Molecules | 2020 | https://conductscience.org/library/papers/33198198 | PubMed |
| 32478277 | Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health. | ACS Omega | 2020 | https://conductscience.org/library/papers/32478277 | PubMed |
| 31156427 | Asteraceae Plants as Sources of Compounds Against Leishmaniasis and Chagas Disease. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31156427 | PubMed |
| 31124384 | Leishmania infantum arginase: biochemical characterization and inhibition by naturally occurring phenolic substances. | J Enzyme Inhib Med Chem | 2019 | https://conductscience.org/library/papers/31124384 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24906989
GET https://conductscience.org/api/papers/v1/24906989/references?page=2